Novartis Eyes Leaner Ophthalmic Business In Xiidra Deal With Bausch + Lomb

 
• By Alaric DeArment
  
Novartis sold Xiidra and ophthalmology pipeline assets to Bausch + Lomb • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business